Cargando…

Barriers to Pediatric Sickle Cell Disease Guideline Recommendations

National guidelines recommend that providers counsel all patients with sickle cell anemia about hydroxyurea (HU) therapy and screen children with sickle cell anemia annually for the risk of stroke with transcranial Doppler (TCD). We surveyed a national convenience sample of sickle cell disease clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabana, Michael D., Kanter, Julie, Marsh, Anne M., Treadwell, Marsha J., Rowland, Michael, Stemmler, Peggy, Bardach, Naomi S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501475/ https://www.ncbi.nlm.nih.gov/pubmed/31106244 http://dx.doi.org/10.1177/2333794X19847026

Ejemplares similares

Improving Preventive Care for Children With Sickle Cell Anemia: A Quality Improvement Initiative
por: Cabana, Michael D., et al.
Publicado: (2020)

Perspectives of individuals with sickle cell disease on barriers to care
por: Phillips, Shannon, et al.
Publicado: (2022)

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA
por: Smeltzer, Matthew P, et al.
Publicado: (2021)

Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care
por: Kanter, Julie, et al.
Publicado: (2020)

Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium
por: Masese, Rita V., et al.
Publicado: (2021)

Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative
por: Treadwell, Marsha J., et al.
Publicado: (2022)

What does it mean to be affiliated with care?: Delphi consensus on the definition of “unaffiliation” and “specialist” in sickle cell disease
por: Lamont, Andrea E., et al.
Publicado: (2022)

Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients
por: Wonkam, Ambroise, et al.
Publicado: (2015)

Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
por: Keller, San, et al.
Publicado: (2017)

Assent, parental consent and reconsent for health research in Africa: thematic analysis of national guidelines and lessons from the SickleInAfrica registry
por: Munung, Nchangwi Syntia, et al.
Publicado: (2022)

Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks
por: Keller, San D, et al.
Publicado: (2014)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2020)

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study
por: Cronin, Robert M., et al.
Publicado: (2019)

Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings
por: Strunk, Crawford, et al.
Publicado: (2020)

International Differences in Outpatient Pain Management: A Survey of Sickle Cell Disease
por: El-Amin, Nadirah, et al.
Publicado: (2019)

Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations
por: Munung, Nchangwi Syntia, et al.
Publicado: (2019)

48847 Assessing Transition Outcomes in Sickle Cell Disease (SCD) Prior To Implementation of A Formal Transition Program
por: Sheppard, Sydney, et al.
Publicado: (2021)

Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care
por: Evensen, Christian T., et al.
Publicado: (2016)

Identified barriers and facilitators to stroke risk screening in children with sickle cell anemia: results from the DISPLACE consortium
por: Phillips, Shannon M., et al.
Publicado: (2021)

Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease
por: Harris, Kelly M., et al.
Publicado: (2023)

Emergency department utilization for sickle cell disease in St. Vincent and the Grenadines
por: Williams, Shelly-Ann, et al.
Publicado: (2021)

An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model
por: Treadwell, Marsha J., et al.
Publicado: (2022)

CureSCi Metadata Catalog–Making sickle cell studies findable
por: Pan, Huaqin, et al.
Publicado: (2022)

Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease
por: Howell, Kristen E., et al.
Publicado: (2023)

Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica
por: Paintsil, Vivian, et al.
Publicado: (2023)

The Effect of an Adapted Digital Mental Health Intervention for Sickle Cell Disease on Engagement: A Pilot Randomized Controlled Trial
por: Parchuri, Ektha, et al.
Publicado: (2023)

Barriers in transition from pediatrics to adult medicine in sickle cell anemia
por: Lebensburger, Jeffrey D, et al.
Publicado: (2012)

Validation of a novel point of care testing device for sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2015)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
por: Colombatti, Raffaella, et al.
Publicado: (2023)

Improved Guideline Adherence With Integrated Sickle Cell Disease and Asthma Care
por: McClain, Brandi L., et al.
Publicado: (2016)

High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study
por: Kanter, Julie, et al.
Publicado: (2019)

Association Between Patent Foramen Ovale and Overt Ischemic Stroke in Children With Sickle Cell Disease
por: Galadanci, Najibah A., et al.
Publicado: (2021)

Coping with complexity: working beyond the guidelines for patients with multimorbidities
por: Treadwell, Julian
Publicado: (2015)

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
por: Heeney, Matthew M., et al.
Publicado: (2022)

Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD
por: Price, Lea, et al.
Publicado: (2007)

Development of a Severity Classification System for Sickle Cell Disease
por: Shah, Nirmish, et al.
Publicado: (2020)

Factors associated with left ventricular hypertrophy in children with sickle cell disease: results from the DISPLACE study
por: Galadanci, Najibah A., et al.
Publicado: (2022)

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study
por: Hankins, Jane S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hss6los27ko6c1g3fk6rl9hu0v